Mutational Analysis and Safety/efficacy in a Phase 2 Multi-Center Investigation of ABI-009 (Nab-Rapamycin) in Patients with Advanced Malignant Perivascular Epithelioid Cell Tumors (Pecoma).
JOURNAL OF CLINICAL ONCOLOGY(2018)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined